LATAM Footprint Sanfer operates across LATAM with a diversified portfolio and recently acquired Vitalis, offering a ready-made distribution network to scale product introductions, expand into new countries, and partner on exclusive licenses.

Diabetes Focus The exclusive Hanmi distribution for efpeglenatide signals a strong diabetes franchise and a readiness to partner on complementary therapies, patient support, and co-promotion opportunities across Sanfer markets.

Animal Health Growth Sanfer Salud Animal presence and regional networks create an attractive entry point for veterinary products, APIs, vaccines, or contract manufacturing for Latin American markets.

Strategic Partnerships Sanfer's history of acquisitions and external investments indicates openness to licensing, co-development, or distribution alliances to accelerate market entry and portfolio expansion.

Manufacturing Capability With mid-market scale and regional manufacturing capabilities, Sanfer could monetize contract manufacturing, fill-finish, and regulatory support for third-party products targeting LATAM growth.